Findings from a recent study challenge the need for high-dose trimethoprim-sulfamethoxazole in managing Stenotrophomonas maltophilia pneumonia, finding lower doses may offer comparable efficacy.
William P. DePasquale, PharmD
Advertisement
DePasquale is a clinical pharmacist specialist in infectious diseases at the Outpatient Parental Antibiotic Therapy Program at the University of Rochester Medical Center.
Articles by William P. DePasquale, PharmD
Advertisement
Latest Updated Articles
A Dose of Clarity: Low- vs High-Dose Trimethoprim-Sulfamethoxazole for Stenotrophomonas maltophilia PneumoniaPublished: January 8th 2026 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Measles Update: February 6, 2026
2
Pritelivir Improves Outcomes in Immunocompromised Patients With Refractory Herpes Simplex Virus
3
HIV in the Black Community: Shifting from Stigma and Health Inequalities to Communication and Care Initiatives
4
Antibiotics Deconstructed: IV Fosfomycin
5